211 related articles for article (PubMed ID: 26851987)
1. Comparison of methods to assess psychiatric medication adherence in methadone-maintained patients with co-occurring psychiatric disorder.
Dunn KE; King VL; Brooner RK
Drug Alcohol Depend; 2016 Mar; 160():212-7. PubMed ID: 26851987
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic Monitors.
Sayner R; Carpenter DM; Blalock SJ; Robin AL; Muir KW; Hartnett ME; Giangiacomo AL; Tudor G; Sleath B
Clin Ther; 2015 Sep; 37(9):1975-85. PubMed ID: 26164785
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of adherence patterns in schizophrenia using electronic monitoring (MEMS®): A six-month post-discharge prospective study.
Misdrahi D; Tessier A; Husky M; Lange AC; Vrijens B; Llorca PM; Baylé FJ
Schizophr Res; 2018 Mar; 193():114-118. PubMed ID: 28663027
[TBL] [Abstract][Full Text] [Related]
4. Optimal recall period in assessing the adherence to antihypertensive therapy: a pilot study.
Doró P; Benko R; Czakó A; Matuz M; Thurzó F; Soós G
Int J Clin Pharm; 2011 Aug; 33(4):690-5. PubMed ID: 21691882
[TBL] [Abstract][Full Text] [Related]
5. Symptom severity, self-reported adherence, and electronic pill monitoring in poorly adherent patients with bipolar disorder.
Sajatovic M; Levin JB; Sams J; Cassidy KA; Akagi K; Aebi ME; Ramirez LF; Safren SA; Tatsuoka C
Bipolar Disord; 2015 Sep; 17(6):653-61. PubMed ID: 26529124
[TBL] [Abstract][Full Text] [Related]
6. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.
Yang J; Ko YH; Paik JW; Lee MS; Han C; Joe SH; Jung IK; Jung HG; Kim SH
Schizophr Res; 2012 Feb; 134(2-3):226-31. PubMed ID: 22133906
[TBL] [Abstract][Full Text] [Related]
7. Psychiatric comorbidity among patients on methadone maintenance therapy and its influence on quality of life.
Teoh Bing Fei J; Yee A; Habil MH
Am J Addict; 2016 Jan; 25(1):49-55. PubMed ID: 26692463
[TBL] [Abstract][Full Text] [Related]
8. Psychometric properties of the Osteoporosis-specific Morisky Medication Adherence Scale in postmenopausal women with osteoporosis newly treated with bisphosphonates.
Reynolds K; Viswanathan HN; O'Malley CD; Muntner P; Harrison TN; Cheetham TC; Hsu JW; Gold DT; Silverman S; Grauer A; Morisky DE
Ann Pharmacother; 2012 May; 46(5):659-70. PubMed ID: 22510666
[TBL] [Abstract][Full Text] [Related]
9. Adherence to hepatitis C treatment in recovering heroin users maintained on methadone.
Sylvestre DL; Clements BJ
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):741-7. PubMed ID: 17700258
[TBL] [Abstract][Full Text] [Related]
10. Impact of co-occurring psychiatric disorders on retention in a methadone maintenance program: an 18-month follow-up study.
Astals M; Díaz L; Domingo-Salvany A; Martín-Santos R; Bulbena A; Torrens M
Int J Environ Res Public Health; 2009 Nov; 6(11):2822-32. PubMed ID: 20049227
[TBL] [Abstract][Full Text] [Related]
11. Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study.
Parker CS; Chen Z; Price M; Gross R; Metlay JP; Christie JD; Brensinger CM; Newcomb CW; Samaha FF; Kimmel SE
J Gen Intern Med; 2007 Sep; 22(9):1254-9. PubMed ID: 17587092
[TBL] [Abstract][Full Text] [Related]
12. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients.
Cacciola JS; Alterman AI; Rutherford MJ; McKay JR; Mulvaney FD
Drug Alcohol Depend; 2001 Feb; 61(3):271-80. PubMed ID: 11164691
[TBL] [Abstract][Full Text] [Related]
13. The impact of mental health comorbidities on adherence to buprenorphine: A claims based analysis.
Litz M; Leslie D
Am J Addict; 2017 Dec; 26(8):859-863. PubMed ID: 29143483
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Motivational Interviewing to Improve Psychotropic Medication Adherence in Adolescents.
Hamrin V; Iennaco JD
J Child Adolesc Psychopharmacol; 2017 Mar; 27(2):148-159. PubMed ID: 27487472
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients.
Carpentier PJ; Krabbe PF; van Gogh MT; Knapen LJ; Buitelaar JK; de Jong CA
Am J Addict; 2009; 18(6):470-80. PubMed ID: 19874168
[TBL] [Abstract][Full Text] [Related]
16. Electronic Real-Time Monitoring Reveals Limited Adherence to Long-Term Opioid Prescriptions in Pain Patients.
Houghton DC; Merritt CR; Miller SN; Mitchell JM; Parker D; Hommel JD; Cunningham KA; Wilkes DM
J Pain Res; 2024; 17():1815-1827. PubMed ID: 38799276
[TBL] [Abstract][Full Text] [Related]
17. Twelve months of electronic monitoring (MEMS®) in the Swedish COAST-study: a comparison of methods for the measurement of adherence in schizophrenia.
Brain C; Sameby B; Allerby K; Lindström E; Eberhard J; Burns T; Waern M
Eur Neuropsychopharmacol; 2014 Feb; 24(2):215-22. PubMed ID: 24359935
[TBL] [Abstract][Full Text] [Related]
18. Type D personality predicts poor medication adherence in patients with heart failure in the USA.
Wu JR; Moser DK
Int J Behav Med; 2014; 21(5):833-42. PubMed ID: 24198039
[TBL] [Abstract][Full Text] [Related]
19. Substance use and response to psychiatric treatment in methadone-treated outpatients with comorbid psychiatric disorder.
Kidorf M; King VL; Peirce J; Gandotra N; Ghazarian S; Brooner RK
J Subst Abuse Treat; 2015 Apr; 51():64-9. PubMed ID: 25468006
[TBL] [Abstract][Full Text] [Related]
20. Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder.
Badiee J; Riggs PK; Rooney AS; Vaida F; Grant I; Atkinson JH; Moore DJ;
AIDS Patient Care STDS; 2012 Jul; 26(7):388-94. PubMed ID: 22686169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
